Top View
- Albumin-Bound Paclitaxel for the Treatment of Refractory Or Relapsed Small-Cell Lung Cancer
- Dainippon Sumitomo Pharma Submits an Application for Anticancer Antibiotic Amrubicin HCI (Brand Name in Japan: CALSED®) in China
- Efficacy of Amrubicin for Non-Small Cell Lung Cancer After Failure of Two Or More Prior Chemotherapy Regimens
- Metabolic Carbonyl Reduction of Anthracyclines — Role in Cardiotoxicity and Cancer Resistance. Reducing Enzymes As Putative Ta
- A Phase 2 Randomized Study of TAS-102 Versus Topotecan Or Amrubicin in Patients Requiring Second-Line Chemotherapy for Small
- Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma
- Therapeutic Polymeric Nanoparticle Compositions
- Irinotecan, Topotecan, Paclitaxel Or Docetaxel for Second-Line Treatment of Small Cell Lung Cancer
- Amrubicin for the Treatment of Small Cell Lung Cancer: Does Effectiveness Cross the Pacific?
- Alternating Chemotherapy with Amrubicin Plus Cisplatin and Weekly Administration of Irinotecan Plus Cisplatin for Extensive-Stage Small Cell Lung Cancer
- The Clinical Effectiveness and Cost-Effectiveness of Topotecan for Small Cell Lung Cancer: a Systematic Review and Economic Evaluation
- Systemic Therapy for Small Cell Lung Cancer
- PD-L1) Antibody (Avelumab) Treatment in Advanced Thymoma Arun Rajan1*† , Christopher R
- Molecular Blueprints for Antitumor Drugs
- Sequential Treatment with SN-38 Followed by 5-Fluorouracil Shows Synergistic Cytotoxic Activity in Small Cell Lung Cancer Cells
- Supplementary Information Natural Product and Natural Product Derived Drugs in Clinical Trials
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- Irinotecan Plus Cisplatin in Patients with Extensive-Disease Poorly Differentiated Neuroendocrine Carcinoma of the Esophagus
- Chemotherapy-Related Leiomyopathy: a Suggested Morphological Explanation for the Intestinal Dysmotility Affecting Patients Treated with Anthracyclines
- Chemotherapy of Lung Cancer: a Global Perspective of the Role of Ifosfamide
- Regimen of 5-Fluorouracil and Cisplatin Increases the Incidence of Extravasation in Patients Undergoing Chemotherapy
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Ovarian Small Cell Carcinoma Complicated by Carcinomatous
- Cancer PRESENTEDBYAMERICA ’ SBIOPHARMACEUTICALRESEARCHCOMPANIES Nearly 900 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer
- An Open Access Database of Licensed Cancer Drugs Pan Pantziarka 1,2, §, Rica Capistrano 1, Arno De Potter 3, Liese Vandeborne 1, Gauthier Bouche 1
- Medicines & Vaccines in Development for Cancer
- Download.Html (Accessed on 23 February 2021)
- VAC Chemotherapy with Valproic Acid for Refractory/Relapsing Small Cell Lung Cancer: a Phase II Study
- Idarubicin, an Anthracycline, Induces Oxidative DNA Damage in The
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- (12) Patent Application Publication (10) Pub. No.: US 2011/0318429 A1 K0 (43) Pub
- Oncology Drugs in the Pipeline
- A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin and Cyclophosphamide in Thymic Epithelial Tumors: a Clinical and Translational Study
- A Absorption, Distribution, Metabolism, Excretion (ADME), 107, 109, 110
- (12) United States Patent (10) Patent No.: US 8.492.406 B2 Zeldis (45) Date of Patent: *Jul
- Leukemia-Myelodysplastic Syndrome and Transplantation
- Systematic Review of the First-Line Chemotherapy for Chemo-Naïve Extensive-Stage Small-Cell Lung Cancer: Network Meta-Analysis